BSW-22189-98482
5 vaccinations
9 coded responses
51 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 604 / IL
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Fever · Fatigue or tirednessAdult check-in
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Erythema, Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Slight facial rash/redness in nasolabial fold area Juvederm injected there 1 1/2 yrs agoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-16
- 2021-01-23
- 2021-02-01
- 2021-02-06
- 2021-02-15
- 2021-02-21
- 2021-04-10
- 2021-07-10
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-01
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-10-03
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Erythema — Feeling: Fair · Headache, NauseaFree text: Redness in nasolabial foldsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Erythema, Pruritus — Feeling: Good · HeadacheFree text: Readiness some itching on face-cheeks nasalabial foldsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-09
Health check-in — day 7, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-10-15
- 2021-10-22
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2022-01-01
- 2022-04-01
-
2022-04-23
Dose 4 — Pfizer-BioNTech
- 2022-05-15
- 2022-05-21
- 2022-05-30
- 2022-06-04
- 2022-07-23
-
2022-10-20
Dose 5 — Pfizer-BioNTech
-
2022-10-21
Survey response — days 1–6 daily, dose 5MedDRA: Pre-existing disease, Swelling face — Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Mild swelling in nasalabial folds-juviderm fillerMedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2022-10-23
-
2022-10-24
Survey response — days 1–6 daily, dose 5MedDRA: Injection site bruising — Feeling: Good · Site: Pain, SwellingFree text: Bruise at injection site -present since day after receiving the vaccineMedDRA releases: 2024-11 · check-in free text available
- 2022-10-25
-
2022-10-26
Survey response — days 1–6 daily, dose 5MedDRA: Injection site bruising — Feeling: GoodFree text: Absorbing bruise at Right arm injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Survey response — day 7, dose 5MedDRA: Injection site bruising — Feeling: GoodFree text: Healing bruise at right arm injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-11-03
- 2022-11-10
- 2022-11-19
- 2022-11-24
-
2022-12-01
Survey response — day 42, dose 5MedDRA: Ageusia, Anosmia, Cough, Dizziness, Headache — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough headache lightheaded ness loss if taste and smellMedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Report sent to call center — day 42, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-02
- 2023-01-19
-
2023-04-20
Survey response — 6 months, dose 5MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-04-23 | Pfizer-BioNTech | No |
| 5 | 2022-10-20 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Slight facial rash/redness in nasolabial fold area Juvederm injected there 1 1/2 yrs ago
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Redness in nasolabial folds
Systemic reaction (other): Readiness some itching on face-cheeks nasalabial folds
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Mild swelling in nasalabial folds-juviderm filler
Systemic reaction (other): Bruise at injection site -present since day after receiving the vaccine
Systemic reaction (other): Absorbing bruise at Right arm injection site
Release 12 — day 7, dose 5
Systemic reaction (other): Healing bruise at right arm injection site
Release 12 — day 42, dose 5
Symptoms: Cough headache lightheaded ness loss if taste and smell
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Pruritus | · | · | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Swelling face | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release